Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 278-154-5 | CAS number: 75268-65-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Test substance is considered to be a skin sensitiser.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 24 November 1992 to 03 February 1993
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- Data from a reliable in vivo test conducted before the enforcement of Commission Regulation (EU) 640/2012 of 06 July 2012 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) are available.
- Specific details on test material used for the study:
- Identification: FAT 40138/D (Cibacron yellow F-4G)
Description: powder, yellow
Batch Number: 275605.26
Purity / Formulation: 79 %
Storage Conditions: At room temperature - Species:
- guinea pig
- Strain:
- other: Pirbright White Strain (Tif: DHP)
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Source: CIBA-GEIGY Limited, Animal Production, 4332 Stein / Switzerland
The test was performed on 10 male and 10 female guinea pigs in the test group and 5 males and 5 females in the control group, respectively, initially weighing between 305 to 399 g. The animals were housed individually in Macrolon cages (Type 3), assigned to the different groups by means of random numbers generated by the random number generator, identified by individual ear tags, kept at a constant room temperature of 22±3 °C, at a relative humidity of 30 to 70 % and a 12 hours light cycle day. The animals received ad libitum standard guinea pig pellets - NAFAG No. 845, Gossau SG and fresh water. All batches of the diet are assayed for nutritive ingredients and contamination level by the manufacturer. Analytical results are available at the animal supply office. The drinking water quality fulfilled the critical parameters in the specifications of the "Schweizerisches Lebensmittelbuch" (Edition 1972). The results of the routine chemical examination of water at source (Grundwasserfassung Stein) as conducted periodically by the water authority (Baudepartement des Kantons Aargau, Abteilung Gewaesserschutz) are available to CIBA-GEIGY Limited, as well as the results of inhouse chemical analysis by the analytical laboratories of the Pharmaceutical Division, CIBA-GEIGY Limited. - Route:
- intradermal
- Vehicle:
- other: in Freund's complete adjuvant and physiological saline (1:1)
- Concentration / amount:
- 5 % / 0.1 ml
- Day(s)/duration:
- Week 1
- Adequacy of induction:
- highest technically applicable concentration used
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 50 %
- Day(s)/duration:
- Week 2
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vaseline
- Concentration / amount:
- 10 %
- Day(s)/duration:
- Week 5
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- The test was performed on 10 male and 10 female guinea pigs in the test group and 5 males and 5 females in the control group, respectively,
- Details on study design:
- RANGE FINDING TESTS:
The following concentrations of FAT 40138/D have been examined on separate animals for the determination of the maximum subirritant concentration: 1, 5, 10, 20, 30, and 50 % in vaseline.
Erythema reactions were observed with 20, 30, and 50 % FAT 40138/D in vaseline.
MAIN STUDY
A. INDUCTION EXPOSURE - INTRADERMAL
- No. of exposures: 1
- Exposure period: Intradermal injection
- Test groups: 1
- Control group: 1
- Site: shaved neck
- Frequency of applications: once
- Duration: -
- Concentrations: 5 %
A. INDUCTION EXPOSURE - EPIDERMAL
- No. of exposures: 1
- Exposure period: 48 hours
- Test groups: 1
- Control group: 1
- Site: neck
- Frequency of applications: once
- Duration: -
- Concentrations: 50 %
B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: Week 5
- Exposure period: 24 hours
- Test groups: 1
- Control group: 1
- Site: flank
- Concentrations: 10 %
- Evaluation (hr after challenge): 24 - Positive control substance(s):
- yes
- Remarks:
- Potassiumdichroinate in a separate study "Test No. 920024"
- Positive control results:
- 1) In the study with Potassium dichroinate, 90 % of the animals were positive at 24 and 48 hours after treatment with a non-irritant test substance concentration of 1 % in vaseline.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 20
- Total no. in group:
- 20
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 1 % in Vaseline
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Potassium dichroinate
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 1 % in Vaseline
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Remarks on result:
- positive indication of skin sensitisation
- Remarks:
- Potassium dichroinate
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- FAT 40138/D was considered to be a skin sensitiser.
- Executive summary:
The sensitisation potential of FAT 40138/D was evaluated in a study conducted according to the Guinea Pig Maximisation test described in OECD Guideline 406 and EU Method B.6, in compliance with GLP. Five Guinea Pigs per sex were used in the control group and 10 per sex were used in the test group. Intradermal and epidermal inductions were carried out in week 1 and week 2 at 5 and 50 % test concentrations, respectively. The test and control guinea-pigs were challenged in week 5 with the epidermal application. The test concentration used for challenge was 10 %. Approximately 24 and 48 hours after the removal of the dressing the application sites were assessed for erythema and oedema using the numerical scoring system according to Draize. Under the experimental conditions employed, 100% of the animals of the test group showed skin reactions (erythema and edema) 24 and 48 hours after removing the dressings. Hence, based on the study findings FAT 40138/D is considered to be a skin sensitiser.
Reference
Under the experimental conditions employed, 100 % of the animals of the test group showed skin reactions (erythema and edema) 24 and 48 hours after removing the dressings.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
- Additional information:
Two studies are available for assessment of skin sensitisation potential of FAT 40138. In a key study, the sensitisation potential of FAT 40138/D was evaluated in a study conducted according to the Guinea Pig Maximisation test described in OECD Guideline 406 and EU Method B.6, in compliance with GLP. Five Guinea Pigs per sex were used in the control group and 10 per sex were used in the test group. Intradermal and epidermal inductions were carried out in week 1 and week 2 at 5 and 50 % test concentrations, respectively. The test and control guinea-pigs were challenged in week 5 with the epidermal application. The test concentration used for challenge was 10 %. Approximately 24 and 48 hours after the removal of the dressing the application sites were assessed for erythema and oedema using the numerical scoring system according to Draize. Under the experimental conditions employed, 100 % of the animals of the test group showed skin reactions (erythema and edema) 24 and 48 hours after removing the dressings. Hence, based on the study findings FAT 40138/D is considered to be a skin sensitiser. In a supporting study, FAT 40138/A was not found to induce sensitisation in guinea pigs. However, the evidence from the recently conducted, GLP-compliant key study cannot be overruled. Hence, FAT 40138 is considered to be a skin sensitiser.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Based on the findings in the skin sensitisation study the test substance should be classified as Skin Sensitiser 1B according to EU Classification, Labelling and Packaging of Substances and Mixtures (CLP) Regulation (EC) No. 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.